Featured Article

Researchers at the UNC Lineberger Comprehensive Cancer Center have identified an enzyme that saps the energy of T cells once they have infiltrated a solid tumor and prevents them from effectively combatting cancer.

Precision Oncology Today

Magazine

AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction

Already a popular topic, the launch of the large language model-based chatbot, ChatGPT, at the end of 2022 increased excitement around artificial intelligence (AI)...
exposome illustration

Fully Exposed: Understanding the Exposome Can Drive the Future of Health and Wellness

The field of exposomics is still in its early stages. Pioneering researchers are grappling with methods to marry multi-omic datasets, blood and urine mass spectrometry data, and even postal code and satellite data to gain insights into the highly complex interface between human biology and environmental exposures--and how it affects human health and wellness.
Michelle Werner

In Conversation with Michelle Werner

Inside Precision Medicine’s editor in chief, Damian Doherty, spoke to Werner, Alltrna's CEO, about her career, her motivation to lead this company, and what rare disease means to her on a personal level.

Trending on Inside Precision Medicine

T-cells' background

Enzyme Identified That Saps T Cells’ Ability to Attack Solid Tumors

Researchers at the UNC Lineberger Comprehensive Cancer Center have identified an enzyme that saps the energy of T cells once they have infiltrated a solid tumor and prevents them from effectively combatting cancer.
Transparent image of a human torso showing inflamed small intestine, as seen in Crohn's disease patients

Wireless Sensor Could Help Crohn’s Patients Get Faster Treatment

A specially designed wireless sensor is effective at detecting Crohn's disease flareups in model mice over a month before lesions appear.
Human bone marrow under the microscope to illustrate myelofibrosis blood cancer

NVIDIA and DCVC Fund Relation for Osteoporosis Drug Discovery

AI firm Relation Tx has raised $35 million in a round led by DCVC and co-led by NVIDIA's venture, NVentures.

Daily News

Related Content

Inside Precision Medicine